Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design

Background: Although revascularization treatment is recommended as the first-line therapy for patients with non-minor acute ischemic stroke (AIS), it only benefits a minority of patients. Previous studies have reported the positive effects of Panax notoginseng saponins (PNS) (Xueshuantong lyophilize...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Luda, Han, Fang, Zhou, Li, Wu, Shengxian, Du, Yawei, Zhang, Dandan, Zhang, Chi, Gao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101545/
https://www.ncbi.nlm.nih.gov/pubmed/33967788
http://dx.doi.org/10.3389/fphar.2021.648921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101545/
https://www.ncbi.nlm.nih.gov/pubmed/33967788
http://dx.doi.org/10.3389/fphar.2021.648921

Ejemplares similares